摘要
Hepatocellular carcinoma (HCC) is a unique cancer entity that can be noninvasively diagnosed using imaging modalities without pathologic confirmation. In 2018, several major guidelines for HCC were updated to include hepatobiliary contrast agent magnetic resonance imaging (HBA-MRI) and contrast-enhanced ultrasound (CEUS) as major imaging modalities for HCC diagnosis. HBA-MRI enables the achievement of high sensitivity in HCC detection using the hepatobiliary phase (HBP). CEUS is another imaging modality with real-time imaging capability, and it is reported to be useful as a second-line modality to increase sensitivity without losing specificity for HCC diagnosis. However, until now, there is an unsolved discrepancy among guidelines on whether to accept ???HBP hypointensity??? as a definite diagnostic criterion for HCC or include CEUS in the diagnostic algorithm for HCC diagnosis. Furthermore, there is variability in terminology and inconsistencies in the definition of imaging findings among guidelines; therefore, there is an unmet need for the development of a standardized lexicon. In this article, we review the performance and limitations of HBA-MRI and CEUS after guideline updates in 2018 and briefly introduce some future aspects of imaging-based HCC diagnosis. Mol
学科与关键词
- Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysisLee, Sunyoung*; Kim, Yeun-Yoon; Shin, Jaeseung; Roh, Yun Ho; Choi, Jin-Young; Chernyak, Victoria; Sirlin, Claude B.European Radiology, 2024, 34(3): 1502-1514.被引 4
- On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter StudyYang, Qi; Zheng, Rongqin; Zhou, Jianhua; Tang, Lina; Zhang, Ruifang; Jiang, Tianan; Jing, Xiang; Liao, Jintang; Cheng, Wen; Zhao, Cheng; Liu, Cun; Dietrich, Chirstoph F.; Cui, Xinwu; Cai, Wenjia; Wu, Jiapeng; Yu, Fei; Cheng, Zhigang; Liu, Fangyi; Han, Zhiyu; Yu, Xiaoling; Yu, Jie*; Liang, Ping*Journal of Ultrasound in Medicine, 2023, 42(12): 2825-2838.
- Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infectionShao, Shuo; Liang, Yingying; Kuang, Sichi; Chen, Jingbiao; Shan, Qungang; Yang, Hao; Zhang, Yao; Wang, Bin; Fowler, Kathryn J.; Wang, Jin*; Sirlin, Claude B.Bosnian Journal of Basic Medical Sciences, 2020, 20(3): 401-410.被引 14
